Paperpal Prime Logo

PPAR Research : Impact Factor & More

eISSN: 1687-4765pISSN: 1687-4757
JournalOpen Access

Key Metrics

CiteScore
4.9
Eigenfactor
0.001 - 0.005
H-Index
57
Impact Factor
< 5
SJR
Q2Drug Discovery
SNIP
0.87
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on PPAR Research

PPAR Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher HINDAWI LTD
Language English
Frequency Irregular
Article Processing ChargesUSD 1500
Publication Time12
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyIrregular
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 12
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in PPAR Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in PPAR Research

Latest Advances in Obesity Treatment by Regulating Adipocyte Thermogenesis
  • 21 Jun 2026
  • PPAR Research
Correction to “Pemafibrate Pretreatment Attenuates Apoptosis and Autophagy During Hepatic Ischemia–Reperfusion Injury by Modulating JAK2/STAT3β/PPARα Pathway”
  • 1 Jan 2026
  • PPAR Research
Correction to "Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?"
  • 1 Jan 2026
  • PPAR research
The Mechanistic Role of PPARγ in Wound Healing
  • 1 Jan 2026
  • PPAR Research
Metabolic Reprogramming and Immune Metabolism in Sepsis: Targeting the PPAR Pathway for Personalized Therapeutic Approaches.
  • 1 Jan 2026
  • PPAR research
RETRACTION: Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells.
  • 1 Jan 2026
  • PPAR research
Latest Advances in Obesity Treatment by Regulating Adipocyte Thermogenesis
  • 21 Jun 2026
  • PPAR Research
Correction to “Pemafibrate Pretreatment Attenuates Apoptosis and Autophagy During Hepatic Ischemia–Reperfusion Injury by Modulating JAK2/STAT3β/PPARα Pathway”
  • 1 Jan 2026
  • PPAR Research
Correction to "Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?"
  • 1 Jan 2026
  • PPAR research
The Mechanistic Role of PPARγ in Wound Healing
  • 1 Jan 2026
  • PPAR Research
Metabolic Reprogramming and Immune Metabolism in Sepsis: Targeting the PPAR Pathway for Personalized Therapeutic Approaches.
  • 1 Jan 2026
  • PPAR research
RETRACTION: Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells.
  • 1 Jan 2026
  • PPAR research

FAQs on PPAR Research